Ars Technica - All content 10月29日 03:34
特朗普政府与泰诺产品致自闭症争议
index_new5.html
../../../zaker_core/zaker_tpl_static/wap/tpl_guoji1.html

 

文章讨论了特朗普政府及其官员将自闭症归咎于泰诺,并引用所谓的证据指控其生产商,引发了广泛的科学和公众争议。

While the underlying cause or causes of autism spectrum disorder remain elusive and appear likely to be a complex interplay of genetic and environmental factors, President Trump and his anti-vaccine health secretary Robert F. Kennedy Jr.—neither of whom have any scientific or medical background whatsoever—have decided to pin the blame on Tylenol, a common pain reliever and fever reducer that has no proven link to autism.

And now, Texas Attorney General Ken Paxton is suing the maker of Tylenol, Kenvue and Johnson & Johnson, who previously sold Tylenol, claiming that they have been “deceptively marketing Tylenol” knowing that it “leads to a significantly increased risk of autism and other disorders.”

To back that claim, Paxton relies on the “considerable body of evidence… recently highlighted by the Trump Administration.”

Read full article

Comments

Fish AI Reader

Fish AI Reader

AI辅助创作,多种专业模板,深度分析,高质量内容生成。从观点提取到深度思考,FishAI为您提供全方位的创作支持。新版本引入自定义参数,让您的创作更加个性化和精准。

FishAI

FishAI

鱼阅,AI 时代的下一个智能信息助手,助你摆脱信息焦虑

联系邮箱 441953276@qq.com

相关标签

特朗普政府 自闭症 泰诺 疫苗 争议
相关文章